Molecular Subtyping with Breast Cancer

(2:11)

The role of molecular subtyping in DLBCL and implications for treatment decisions

(2:21)

Molecular Subtyping of Breast Cancer

(2:11)

Molecular subtyping/profiling of upper-GI cancers

(24:37)

Dr. Cristofanilli Discusses Molecular Subtyping in Breast Cancer

(1:51)

Dr. Grivas on the Future of Molecular Subtyping in Urothelial Cancer

(1:9)

Neil Barth, Agendia: Molecular Subtypes in Breast Cancer Challenging the Clinical Subtyping Paradigm

(15:14)

Novel approaches to trial design in the era of molecular subtyping

(29:30)

Current limitations and research on molecular subtyping in the treatment of urothelial carcinoma

(1:11)

Molecular Subtype of PDAC

(9:3)

Update 3: Molecular Subtyping in Colorectal Cancer

(23:32)

In A Nutshell: Endometrial Cancer Molecular Subtypes

(14:32)

Molecular Subtyping Improves Breast Cancer Treatment

(2:4)

Importance of understanding molecular subtypes in endometrial cancer

(37)

Dr. Goodman on the Need for Molecular Subtyping in T-Cell Lymphomas

(46)

John Strickler, MD, shares thoughts on molecular subtyping of pancreatic cancer

(58)

GUSTO: use of gene expression patterns to identify unique molecular subtypes in MIBC

(1:44)

Molecular subtyping provides greater precision treatment planning for breast cancer patients

(1:36)

Molecular subtyping in prostate cancer: Felix Feng, MD

(2:37)